GSK3B and early-onset autosomal dominant Alzheimer disease: In Alzheimer’s disease, GSK3β increases Drp1-dependent GTPase activity and results in modified neurons being more vulnerable to apoptotic signals; in contrast, blocking GSK3β-induced Drp1 phosphorylation efficiently protects neurons against apoptosis [130].